Oral administration is perhaps the most commonly used and acceptable route for drug
delivery to patients, mainly due to its non-invasiveness, simplicity, and versatility …

Importance The comparative clinical benefit of nonstatin therapies that reduce low-density
lipoprotein cholesterol (LDL-C) remains uncertain. Objective To evaluate the association …

Abstract Objective This EAS Consensus Panel critically appraised evidence relevant to the
benefit to risk relationship of functional foods with added plant sterols and/or plant stanols …

The role of inflammation in the propagation of atherosclerosis and susceptibility to
cardiovascular (CV) events is well established. Of the wide array of inflammatory biomarkers …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Background & aims To update the European Association for the Study of Diabetes (EASD)
clinical practice guidelines for nutrition therapy, we conducted a systematic review and meta …

The leadership of the National Lipid Association convened an Expert Panel to develop a
consensus set of recommendations for patient-centered management of dyslipidemia in …

Figure 2. Regulation of the Rho GTPase cycle. Rho protein cycle between an inactive GDP-
bound and an active GTP-bound state. Inhibition of the mevalonate synthesis by statins …

Background Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density
lipoprotein (LDL) cholesterol when added to statin treatment. However, the effect of …

Background Epidemiological studies have consistently associated nut consumption with
reduced risk for coronary heart disease. Subsequently, many dietary intervention trials …